AnodyneWiki

Tetrazepam

Tetrazepam
Tetrazepam
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass288.77 g/mol [1]
Melting point144 °C [1]
Predicted LogP3.2 [1]
Structural Identifiers
[]
Molecular formulaC16H17ClN2O
IUPAC name7-chloro-5-(cyclohexen-1-yl)-1-methyl-3H-1,4-benzodiazepin-2-one
SMILESCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CCCCC3
InChIInChI=1S/C16H17ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h5,7-9H,2-4,6,10H2,1H3
InChIKeyIQWYAQCHYZHJOS-UHFFFAOYSA-N
CAS number10379-14-3
UNIIFO92091VP8
PubChem CID25215
Pharmacokinetics[]
Elimination half-life3–26 hours
Routes of administrationOral

Tetrazepam (also known as Myolastan, Musaril, Clinoxan, Cb 4261, Cb-4261, 7-chloro-5-(cyclohex-1-en-1-yl)-1-methyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one, 7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2h-1,4-benzodiazepin-2-one, 233-837-7, Ro 06-6657 or 4261 cb) is a substance of the aniline and benzodiazepine class.

Chemistry

 []

Tetrazepam is achiral.

Tetrazepam matches Lipinski's rule of five.

Pharmacology

 []

  • Brazil: Tetrazepam is a B1.[3]
  • Canada: Tetrazepam is a Schedule IV.
  • Germany: Tetrazepam is Prescription only/Anlage III.
  • United Kingdom: Tetrazepam is a Class C under the "Misuse of Drugs Act 1971".
  • United States: Tetrazepam is a Schedule IV under the "Controlled Substances Act".

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 25215, Tetrazepam. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/25215
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Tetrazepam. UNII: FO92091VP8. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/FO92091VP8
  3. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 18:01:03
drugspromissing (no DrugsPRO reagent data)2026-11-20 18:00:59
erowidmissing (no Erowid substance of that name)2026-11-20 18:00:59
gsrsok2026-11-20 18:00:59
hmdbmissing (hmdb.ca refused automated access to HMDB0042029)2026-11-20 18:00:59
keggok2026-11-20 18:01:00
pubchemok2026-11-20 18:00:59
redditmissing (no r/tripreports posts mention it)2026-11-20 18:00:59
sidermissing (not in SIDER)2026-11-20 18:00:59
structureok2026-11-20 18:00:59
wikipediaok2026-11-20 18:00:59